These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 25577552

  • 1. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
    Kang HJ, Kim IH, Sung CO, Shim JH, Yu E.
    Virchows Arch; 2015 Apr; 466(4):403-13. PubMed ID: 25577552
    [Abstract] [Full Text] [Related]

  • 2. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M.
    Int J Clin Exp Pathol; 2015 Apr; 8(1):862-6. PubMed ID: 25755787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
    Hyuga S, Wada H, Eguchi H, Otsuru T, Iwgami Y, Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M.
    Int J Oncol; 2017 Oct; 51(4):1179-1190. PubMed ID: 28849188
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.
    Aomatsu N, Yashiro M, Kashiwagi S, Kawajiri H, Takashima T, Ohsawa M, Wakasa K, Hirakawa K.
    BMC Cancer; 2014 Jun 04; 14():400. PubMed ID: 24893880
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
    Choi SW, Kim JY, Park JY, Cha IH, Kim J, Lee S.
    Hum Pathol; 2008 Sep 04; 39(9):1317-22. PubMed ID: 18440050
    [Abstract] [Full Text] [Related]

  • 8. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
    Hua KT, Liu YF, Hsu CL, Cheng TY, Yang CY, Chang JS, Lee WJ, Hsiao M, Juan HF, Chien MH, Yang SF.
    Sci Rep; 2017 Jun 30; 7(1):4466. PubMed ID: 28667334
    [Abstract] [Full Text] [Related]

  • 9. Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival.
    Williams E, Martin S, Moss R, Durrant L, Deen S.
    Virchows Arch; 2012 Jul 30; 461(1):33-9. PubMed ID: 22699808
    [Abstract] [Full Text] [Related]

  • 10. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ.
    J Clin Oncol; 2003 Feb 01; 21(3):473-82. PubMed ID: 12560438
    [Abstract] [Full Text] [Related]

  • 11. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M, Leite KR, Pontes-Junior J, Segre CC, Reis ST, Srougi M, Dall'Oglio MF.
    Int Braz J Urol; 2013 Feb 01; 39(4):484-92. PubMed ID: 24054396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
    Finkelmeier F, Canli Ö, Peiffer KH, Walter D, Tal A, Koch C, Pession U, Vermehren J, Trojan J, Zeuzem S, Piiper A, Greten FR, Grammatikos G, Waidmann O.
    PLoS One; 2018 Feb 01; 13(7):e0200855. PubMed ID: 30011326
    [Abstract] [Full Text] [Related]

  • 14. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.
    Kim JY, Shin HJ, Kim TH, Cho KH, Shin KH, Kim BK, Roh JW, Lee S, Park SY, Hwang YJ, Han IO.
    J Cancer Res Clin Oncol; 2006 May 01; 132(5):302-8. PubMed ID: 16416108
    [Abstract] [Full Text] [Related]

  • 15. CA9 expression as a prognostic factor in renal clear cell carcinoma.
    Soyupak B, Erdoğan S, Ergin M, Seydaoğlu G, Kuzgunbay B, Tansuğ Z.
    Urol Int; 2005 May 01; 74(1):68-73. PubMed ID: 15711113
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH.
    Br J Cancer; 2007 Jan 15; 96(1):104-9. PubMed ID: 17213826
    [Abstract] [Full Text] [Related]

  • 17. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B, Gonul II, Buyukberber S, Afsar B, Gumusay O, Algın E, Turan N, Ozet A, Benekli M, Coskun U.
    Tumour Biol; 2015 Nov 15; 36(11):8471-8. PubMed ID: 26026587
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B, Ekinci O, Dursun A, Akyurek N.
    Pathol Res Pract; 2017 Jul 15; 213(7):783-792. PubMed ID: 28554753
    [Abstract] [Full Text] [Related]

  • 19. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
    Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL.
    J Clin Oncol; 2006 Feb 10; 24(5):727-35. PubMed ID: 16418497
    [Abstract] [Full Text] [Related]

  • 20. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL.
    Cancer Res; 2001 Nov 01; 61(21):7992-8. PubMed ID: 11691824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.